Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Citi
Deloitte
Federal Trade Commission
Julphar
Mallinckrodt
Cipla
Merck
Johnson and Johnson
McKesson

Generated: August 20, 2017

DrugPatentWatch Database Preview

FLUVOXAMINE MALEATE Drug Profile

« Back to Dashboard

Which patents cover Fluvoxamine Maleate, and what generic Fluvoxamine Maleate alternatives are available?

Fluvoxamine Maleate is a drug marketed by Eci Pharms Llc, Actavis Elizabeth, Apotex, Sun Pharm Inds, Torrent Pharms Ltd, Mylan, Anchen Pharms, Upsher-smith Labs, Teva, Watson Labs, Ani Pharms Inc, and Synthon Pharms. and is included in sixteen NDAs.

The generic ingredient in FLUVOXAMINE MALEATE is fluvoxamine maleate. There are eleven drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the fluvoxamine maleate profile page.

Summary for Tradename: FLUVOXAMINE MALEATE

Patents:0
Applicants:12
NDAs:16
Suppliers / Packagers: see list12
Bulk Api Vendors: see list80
Clinical Trials: see list224
Patent Applications: see list5,908
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:FLUVOXAMINE MALEATE at DailyMed

Pharmacology for Tradename: FLUVOXAMINE MALEATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms Inc
FLUVOXAMINE MALEATE
fluvoxamine maleate
TABLET;ORAL075898-003Mar 12, 2001DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva
FLUVOXAMINE MALEATE
fluvoxamine maleate
TABLET;ORAL075893-003Sep 10, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan
FLUVOXAMINE MALEATE
fluvoxamine maleate
TABLET;ORAL075889-002Nov 29, 2000ABRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
FLUVOXAMINE MALEATE
fluvoxamine maleate
TABLET;ORAL075894-001Apr 18, 2001DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan
FLUVOXAMINE MALEATE
fluvoxamine maleate
TABLET;ORAL075889-003Nov 29, 2000ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Mallinckrodt
Teva
Express Scripts
Citi
Covington
Accenture
US Department of Justice
Chinese Patent Office
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot